Dr. Charles-Schoeman is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
UCLA Medical Center
1000 Veteran Ave., Rm 32-59, Rehab Center
Los Angeles, CA 90095Phone+1 310-825-2448Fax+1 310-825-2448
Education & Training
- UCLA David Geffen School of Medicine/UCLA Medical CenterFellowship, Rheumatology, 2003 - 2006
- UCLA David Geffen School of Medicine/UCLA Medical CenterResidency, Internal Medicine, 2000 - 2003
- David Geffen School of Medicine at UCLAClass of 2000
Certifications & Licensure
- CA State Medical License 2002 - 2025
- American Board of Internal Medicine Rheumatology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013
- Fellow (FACR) American College of Rheumatology
Publications & Presentations
PubMed
- 90 citationsEffects of tofacitinib and other DMARDs on lipid profiles in rheumatoid arthritis: implications for the rheumatologist.Christina Charles-Schoeman, Miguel A. González-Gay, Irina Kaplan, M. Boy, Jamie Geier
Seminars in Arthritis and Rheumatism. 2016-08-01 - 149 citationsPotential mechanisms leading to the abnormal lipid profile in patients with rheumatoid arthritis versus healthy volunteers and reversal by tofacitinib.Christina Charles-Schoeman, Roy Fleischmann, Jean Davignon, Howard Schwartz, Scott M. Turner
Arthritis & Rheumatology. 2015-03-01 - 81 citationsRisk of major adverse cardiovascular events with tofacitinib versus tumour necrosis factor inhibitors in patients with rheumatoid arthritis with or without a history o...Christina Charles-Schoeman, Maya H Buch, Maxime Dougados, Deepak L Bhatt, Jon T Giles
Annals of the Rheumatic Diseases. 2023-01-01
Press Mentions
- Golden Age of Rheumatology: Comparing Drug-Associated Risk in Pre-Biologic Era vs. TodayJune 21st, 2022
- Cardiovascular Risks & Insights from ACR Convergence 2021December 9th, 2021
- Statins Can Cause Disabling Muscle DiseaseJune 6th, 2017
- Join now to see all
Professional Memberships
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: